PathoVax LLC is a Johns Hopkins start-up biotechnology company headquartered in Baltimore, Maryland. Founded in 2014, the company has been focused on different medical applications for its proprietary Papillomavirus Virus-like Particle (VLP) platform.
Management & Operations Team
Joshua Wang Ph.D.
Co-Founder & CEO
Wenbin Lai Ph.D., MBA
Chemistry, Manufacturing & Controls Advisor (Singapore)
Dr Robert (‘”Bob”) Becker, PhD MBA is an experienced executive with a proven history in fostering partnerships with product development, cGMP manufacturing, clinical development and regulatory affairs
Robert "Bob" Becker Ph.D., MBA
Mr Jay Nadkarni joins PathoVax with 20+ years of experience in all aspects of new product commercialization and licensing; and has to his credit many successful licensing deals brought to fruition. He has a commendable track record in Innovation Management, Licensing, Business Development, and Technology Transfers for Biopharmaceuticals, Biologics, and Rx / OTC Pharmaceuticals all over the world with emphasis on Tier-1&2 Emerging Markets